| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-71 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-71 |
| filingDate |
1994-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4365ac57cfd3de3b39626c2d7db602d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52609cada76e170ddd54e59426ed0180
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f1a6c2e25235f2b6f08a0418073c205 |
| publicationDate |
1994-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9425057-A1 |
| titleOfInvention |
Kgf receptor-derived antagonists of kgf binding |
| abstract |
The invention provides KGFR peptides which inhibit binding between keratinocyte growth factor (KGF) and its receptor. The sequence of the peptides is derived from regions in the receptor which specifically bind the growth factor. Also provided are pharmaceutical compositions and methods of inhibiting the interaction of KGF and the receptor in a patient to treat various carcinomas. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017162604-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5837834-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6743422-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5846713-A |
| priorityDate |
1993-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |